These emerging treatments, Tirzepatide , represent a remarkable advancement in managing type 2 diabetes and possibly associated conditions . These drugs are classified as GLP-1 receptor agonists , https://nanaexbe257419.onzeblog.com/41728223/tirzepatide-a-thorough-dive-into-glp-1-compounds